Adaptimmune Therapeutics PLC

ADAPY

Financials

10-QQ2 ended 06/30/2508/13/25 10-QQ1 ended 03/31/2505/13/25 10-KFY 202403/24/25 10-QQ3 ended 09/30/2411/13/24 10-QQ2 ended 06/30/2408/12/24

Disclosures

8-KCurrent report10/20/25 8-KCurrent report09/26/25 8-KCurrent report09/12/25 8-KCurrent report09/08/25 8-KCurrent report08/29/25

Prospectuses and Registrations

424B3Prospectus11/13/25 POS AMPost-effective amendment10/28/25 S-8 POSPost-effective amendment (S-8)10/28/25 S-8 POSPost-effective amendment (S-8)10/28/25 S-8 POSPost-effective amendment (S-8)10/28/25

Proxies

DEF 14ADefinitive proxy04/25/25 PRE 14APreliminary proxy04/15/25 DEF 14ADefinitive proxy04/11/24 PRE 14APreliminary proxy04/01/24 DEF 14ADefinitive proxy04/13/23

Ownership

SC 13GBeneficial ownership02/17/26 SC 13G/ABeneficial ownership (amended)11/14/25 Form 3Initial insider ownership10/08/25 Form 4Insider transaction09/03/25 144Proposed sale of securities09/02/25

Other

RWRegistration withdrawal04/22/26 EFFECTRequest for effectiveness11/14/25 15-12GCertification of termination of registration11/13/25 25Removal from listing10/28/25 ARSAnnual report to shareholders04/25/25